Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Type of information:
experimental study
Adequacy of study:
key study
Study period:
20 Nov 2003 - 07 Jan 2004
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2004
Report date:
2004

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Version / remarks:
adopted 1997
Deviations:
yes
Remarks:
2-aminoanthracene was used as the sole indicator of the efficacy of the S9-mix
GLP compliance:
yes (incl. QA statement)
Remarks:
Bayerisches Landesamt für Arbeitsschutz, Arbeitsmedizin und Sicherheitstechnik, München, Germany
Type of assay:
bacterial reverse mutation assay

Test material

Constituent 1
Chemical structure
Reference substance name:
methyl N-{[dimethoxy(methyl)silyl]methyl}carbamate
Cas Number:
23432-65-7
Molecular formula:
C6H15NO4Si
IUPAC Name:
methyl N-{[dimethoxy(methyl)silyl]methyl}carbamate
Test material form:
liquid

Method

Target gene:
His operon
Species / strainopen allclose all
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98 and TA 100
Species / strain / cell type:
S. typhimurium TA 102
Metabolic activation:
with and without
Metabolic activation system:
cofactor supplemented post-mitochondrial fraction (S9 mix), prepared from the livers of rats treated with Phenobarbital/beta-Naphtoflavone.
Test concentrations with justification for top dose:
31.6, 100, 316, 1000, 2500, 5000 µg/plate
Vehicle / solvent:
- Vehicle/solvent used: DMSO
- Justification for choice of solvent/vehicle: The solvent was compatible with the survival of the bacteria and the S9 activity.
Controls
Untreated negative controls:
yes
Negative solvent / vehicle controls:
yes
True negative controls:
no
Positive controls:
yes
Positive control substance:
sodium azide
methylmethanesulfonate
other: 4-nitro-o-phenylene-diamine (4-NOPD), 2-aminoanthracene (2-AA)
Remarks:
Without S9: sodium azide (10 µg/plate for TA 100 and TA 1535); 4-NOPD (10 and 40 µg/plate for TA 98 and TA 1537); MMS (1 µL/plate for TA 102); With S9: 2-AA (2.5 µg/plate for TA 98, TA 100, TA 1535, TA 1537; 10 µg/plate for TA 102)
Details on test system and experimental conditions:
METHOD OF APPLICATION: in agar (plate incorporation); preincubation

DURATION
- Preincubation period: 60 minutes
- Exposure duration: 48 h

NUMBER OF REPLICATIONS: 3 plates per concentration in two independent experiments (plate incorporation and preincubation)

DETERMINATION OF CYTOTOXICITY
- Method: reduced background lawn, reduction in the number of revertants, degree of survival of treated cultures

METABOLIC ACTIVATION
The S9 fraction was stored in liquid nitrogen. The S9 mix was freshly prepared on the day of the test according to AMES (1933): containing 15% S9 and the following components (final concentrations):
- 8 mM MgCl2
- 33 mM KCI-salt solution
- 5 mM glucose-6-phosphate
- 5 mM NADP
in 100 mM phosphate buffer, pH 7.4
Evaluation criteria:
A test item is considered as mutagenic if:
- a dose-related increase in the number of revertants occurs and/or
- a reproducible biologically relevant positive response for at least one of the dose groups occurs in at least one strain with or without metabolic activation
A biologically relevant increase is described as follows:
- if in strains TA 100 and TA 102 the number of reversions is at least twice as high
- if in strains TA 1535, TA 1537 and TA 98 the number of reversions is at least three times higher
as compared to the spontaneous reversion rate.
Statistics:
Mean values and standard deviation were calculated

Results and discussion

Test resultsopen allclose all
Key result
Species / strain:
S. typhimurium TA 1535
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 1537
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 98
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 100
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Key result
Species / strain:
S. typhimurium TA 102
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
no cytotoxicity nor precipitates, but tested up to recommended limit concentrations
Vehicle controls validity:
valid
Untreated negative controls validity:
valid
Positive controls validity:
valid
Additional information on results:
TEST-SPECIFIC CONFOUNDING FACTORS
- Precipitation: no precipitation was reported

RANGE-FINDING/SCREENING STUDIES:
In a preliminary toxicity test TA 98 and TA 100 were treated with the test item up to 5000 µg/plate. No toxicity was observed up to 5000 µg/plate.

COMPARISON WITH HISTORICAL CONTROL DATA: no data given

Any other information on results incl. tables

Table 1: Test results of main test 1 (Plate incorporation test).

With or without S9-Mix

Test substance concentration

Mean number of revertant colonies per plate in the plate incorporation test

(μg/plate)

(average of 3 plates±standard deviation)

 

Base-pair substitution type

Frameshift type

 

TA 100

TA 102

TA 1535

TA1537

TA98

A. dest.

124±8

327±6

27±4

12±7

31±3

Solvent control

99±11

273±16

28±7

11±6

33±2

31.6

106±19

286±16

24±5

14±6

36±2

100

109±4

279±11

22±6

15±5

27±8

316

104±9

301±7

23±5

15±2

33±6

1000

115±4

294±8

21±4

17±3

27±2

2500

103±14

319±26

19±4

12±3

28±8

5000

116±5

308±19

24±9

12±6

30±8

Positive controls, –S9

Name

sodium azide

MMS

sodium azide

4-NOPD

4-NOPD

Concentrations (μg/plate)

10

1 µL/plate

10

40

10

Average of 3 plates±sd

402±28

1724±129

1032±46

179±11

774±59

+

A. dest.

124±22

355±56

12±2

15±4

46±9

+

Solvent control

116±13

289±31

11±3

13±1

36±7

+

31.6

116±7

330±28

15±7

17±2

38±2

+

100

108±16

369±40

21±1

14±1

41±4

+

316

116±14

330±23

16±7

13±9

38±12

+

1000

113±17

360±19

16±4

19±3

35±1

+

2500

128±4

352±5

11±3

13±4

34±4

+

5000

130±9

375±23

15±6

13±3

38±6

Positive controls,+S9

Name

2-aminoanthracene

2-aminoanthracene

2-aminoanthracene

2-aminoanthracene

2-aminoanthracene

Concentrations (μg/plate)

2.5

10

2.5

2.5

2.5

Average of 3 plates±sd

1991±36

804±20

226±29

282±9

1207±142

 

Table 2: Test results of main test 2 (Pre-incubation test).

With or without S9-Mix

Test substance concentration

Mean number of revertant colonies per plate in the pre-incubation test

(μg/plate)

(average of 3 plates±standard deviation)

 

Base-pair substitution type

Frameshift type

 

TA 100

TA 102

TA 1535

TA1537

TA98

A. dest.

113±11

192±19

21±4

17±6

35±5

Solvent control

99±5

141±8

17±4

11±

27±4

31.6

128±3

166±12

16±4

17±7

25±4

100

115±18

159±11

20±1

17±4

26±3

316

117±21

151±1

24±2

15±4

25±3

1000

114±1

154±20

17±4

17±1

25±3

2500

123±5

131±9

24±1

17±2

24±5

5000

123±10

166±6

23±3

17±1

31±4

Positive controls, –S9

Name

sodium azide

MMS

sodium azide

4-NOPD

4-NOPD

Concentrations (μg/plate)

10

1 µL/plate

10

40

10

Average of 3 plates±sd

540±49

2246±80

1168±84

152±15

848±29

+

A. dest.

143±12

304±32

16±6

24±8

45±5

+

Solvent control

128±9

211±39

11±2

11±0

39±11

+

31.6

132±10

258±15

18±2

13±3

38±10

+

100

127±12

246±1

13±6

18±8

43±12

+

316

120±8

223±17

15±3

14±2

33±4

+

1000

128±3

221±25

19±4

11±4

42±2

+

2500

122±25

209±12

12±6

15±4

38±8

+

5000

122±22

233±31

21±3

16±2

35±9

Positive controls,+S9

Name

2-aminoanthracene

2-aminoanthracene

2-aminoanthracene

2-aminoanthracene

2-aminoanthracene

Concentrations (μg/plate)

2.5

10

2.5

2.5

2.5

Average of 3 plates±sd

2373±144

839±197

178±31

204±44

2033±238

MMS - Methylmethanesulfonate

4 -NOPD - 4 -nitro-o-phenylene-diamine

Applicant's summary and conclusion

Conclusions:
Interpretation of results::
negative